djc795's profile picture. Interventional and Structural Cardiologist.  Dir. of Clinical and Outcomes Research, @crfheart.  Director of Acad. Affairs, @StFrancis_LI. Die-hard Red Sox fan.

David J. Cohen, MD, MSc

@djc795

Interventional and Structural Cardiologist. Dir. of Clinical and Outcomes Research, @crfheart. Director of Acad. Affairs, @StFrancis_LI. Die-hard Red Sox fan.

David J. Cohen, MD, MSc hat repostet

Value-based care has largely fallen short in the US. CMS’s new Ambulatory Specialty Model tries to change that by bringing specialists to the table In @JAMA_current, we ask whether this is true innovation, or just an imitation of past failures? bit.ly/3XpG7Wt

rkwadhera's tweet image. Value-based care has largely fallen short in the US. CMS’s new Ambulatory Specialty Model tries to change that by bringing specialists to the table

In @JAMA_current, we ask whether this is true innovation, or just an imitation of past failures? 
bit.ly/3XpG7Wt

David J. Cohen, MD, MSc hat repostet

Remember MedTwitter? It was a great resource to connect with colleagues and discuss research and clinical cases. Roon.com is a platform that includes a special feature making it easier to do tutorials and journal clubs. Disclosure - I am a founding member


David J. Cohen, MD, MSc hat repostet

Tune in to @OPCILive for a journal club discussion of our recent #TCT2025 late breaker and @JACCJournals publication about AI ECG transforming U.S. #STEMI care!

RobertHermanMD's tweet image. Tune in to @OPCILive for a journal club discussion of our recent #TCT2025 late breaker and @JACCJournals publication about AI ECG transforming U.S. #STEMI care!

David J. Cohen, MD, MSc hat repostet

Watch Now | OPCI Journal Club: “Immediate vs Staged Complete Revascularisation during Index Admission in Patients with St-segment Elevation Myocardial Infarction and Multivessel Disease (OPTION–STEMI).” Presented by Dr. Youngkeun Ahn with panelists @djc795 @ziadalinyc @DrAllenJ


David J. Cohen, MD, MSc hat repostet

FDA approves TELLTALE! Electrosurgical leaflet modification tools approved after outstanding clinical safety and efficacy in pivotal trial. @AdamGreenbaumMD @jamiemccabeMD @OKhaliqueMD @djc795 @CardioBusiness @NIH jacc.org/doi/abs/10.101…


David J. Cohen, MD, MSc hat repostet

Mark your calendar for #NYValves2026 — where visionaries unite to shape the future of structural heart care!🗽 Get ready for dynamic discussions, live cases, and hands-on training.✨ Sign up for CRF notifications and stay ahead of the latest updates and openings! 📢…


David J. Cohen, MD, MSc hat repostet

After two years and thousands of manuscripts, I’ve learned that the real work of an editor isn’t gatekeeping — it’s partnership. My latest @JACCJournals Editor’s Page: The Partnership 🔗 jacc.org/doi/10.1016/j.… #MedTwitter #AcademicMedicine #Cardiology @YaleMed @YaleSPH

hmkyale's tweet image. After two years and thousands of manuscripts, I’ve learned that the real work of an editor isn’t gatekeeping — it’s partnership.

My latest @JACCJournals Editor’s Page: The Partnership

🔗 jacc.org/doi/10.1016/j.…

#MedTwitter #AcademicMedicine #Cardiology @YaleMed @YaleSPH

David J. Cohen, MD, MSc hat repostet

I agree with @drjohnm’s perspective on LAAC. As an additional piece of orthogonal evidence: Our group, as well as multiple others, have shown that AI-ECG can predict AF from sinus ECGs. When you apply these models or try to directly train an AI-ECG model to predict stroke, they…

Great comments below: "but at this stage it seems appropriate to pause and reflect." Good luck with that Professor. I've been encouraging a pause and reflection on 5 continents, with little success. All of this could have been predicted from PROTECT and PREVAIL data.



David J. Cohen, MD, MSc hat repostet

Watch Now | OPCI Journal Club: “Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation” presented by Gilles Lemesle. Joined by panelists @djc795 @DrAllenJ @JWMoses @ESHLOF and Dr. Glenford Robinson. opci.live/opci-lives/asp…


David J. Cohen, MD, MSc hat repostet

In the US, 10 million older people, two-thirds of them women, have mild or greater valvular heart disease (VHD), based on data from the PREVUE-VALVE study. To optimize screening, "we need to understand the true prevalence of VHD–how much there is," said @djc795. #TCT2025

TCTMD's tweet image. In the US, 10 million older people, two-thirds of them women, have mild or greater valvular heart disease (VHD), based on data from the PREVUE-VALVE study. To optimize screening, "we need to understand the true prevalence of VHD–how much there is," said @djc795. #TCT2025…

David J. Cohen, MD, MSc hat repostet

Ready to share your science at #CTO2026? 🚀This is your chance to present to global leaders in complex PCI and make your voice heard! Showcase your expertise and join the conversation shaping the future of #interventionalcardiology. 📅Submissions open next week!…


David J. Cohen, MD, MSc hat repostet

My @TCTMD video with @SuzanneJBaron and @MatthiasBossard discuss SHORT-CUT and VICTORY trial. How does / will this data change IVL use? @jgranadacrf @djc795 @NMerke @alaide_chief @Hragy @realarainmd @mirvatalasnag @Dr_AshokSeth @ncurzen @sbrugaletta @mornei2011

Suzanne Baron (@SuzanneJBaron) and Matthias Bossard (@MatthiasBossard) sit down with Mamas Mamas (@mmamas1973) to discuss the Short-Cut and VICTORY trials presented earlier this week at #TCT2025. Watch the full video: tctmd.com/videos/beyond-…



David J. Cohen, MD, MSc hat repostet

Watch Now | OPCI Journal Club: “Tricuspid Valve Outcomes by Baseline Tricuspid Regurgitation Severity: The TRISCEND II Trial.” @PhilippLurz @CathElectroSurg @djc795 opci.live/journal-club/


David J. Cohen, MD, MSc hat repostet

Goodbye #TCT2025 , thank you for the science , and the puppies, see you in San Diego #TCT2026 TCT is like good wine, matures with aging! ⁦@crfheart⁩ Special thanks to ⁦@djc795⁩ ⁦@ColletCarlos⁩ for an amazing program and for all the SoMe ambassadors

Hragy's tweet image. Goodbye #TCT2025 , thank you for the science , and the puppies, see you in San Diego #TCT2026 TCT is like good wine, matures with aging! ⁦@crfheart⁩ 
Special thanks to ⁦@djc795⁩  ⁦@ColletCarlos⁩ for an amazing program and for all the SoMe ambassadors

David J. Cohen, MD, MSc hat repostet

The final day of #TCT2025 kicks off today! Before you delve into today's sessions, watch @sahilparikhmd and David Cohen discuss yesterday's late-breaking trials. tctmd.com/videos/tct-202…


David J. Cohen, MD, MSc hat repostet

The PARTHENOPE Trial, which evaluated an individualized strategy of post-PCI antiplatelet therapy using the DAPT Score compared with standard of care, broke new ground on a number of fronts. @djc795, @EricSecemskyMD and I wrote about it in @JACCJournals. jacc.org/doi/10.1016/j.…


David J. Cohen, MD, MSc hat repostet

PREVUE-VALVE Novel approach to pt recruitment! VHD projected to increase by nearly 4 million by 2060--TR prevalence highest (10.7% of pts with significant VHD)!! @djc795 @BrenerMickey @ACCinTouch @escardio @TCTMD @TCTConference


David J. Cohen, MD, MSc hat repostet

@TCTConference PREVUE trial seminal study of VHD prevalence. Tricuspid regurgitation leads in prevalence inpatients 65-85!! Likely all prevalences an underestimate. @ACCinTouch @escardio

hahn_rt's tweet image. @TCTConference PREVUE trial seminal study of VHD prevalence.  Tricuspid regurgitation leads in prevalence inpatients 65-85!!  Likely all prevalences an underestimate. @ACCinTouch @escardio
hahn_rt's tweet image. @TCTConference PREVUE trial seminal study of VHD prevalence.  Tricuspid regurgitation leads in prevalence inpatients 65-85!!  Likely all prevalences an underestimate. @ACCinTouch @escardio
hahn_rt's tweet image. @TCTConference PREVUE trial seminal study of VHD prevalence.  Tricuspid regurgitation leads in prevalence inpatients 65-85!!  Likely all prevalences an underestimate. @ACCinTouch @escardio
hahn_rt's tweet image. @TCTConference PREVUE trial seminal study of VHD prevalence.  Tricuspid regurgitation leads in prevalence inpatients 65-85!!  Likely all prevalences an underestimate. @ACCinTouch @escardio

David J. Cohen, MD, MSc hat repostet

🧪✨ It’s the final late-breaker session at #TCT2025 — and it’s one you won’t want to miss! Experience the unveiling of groundbreaking research presented in collaboration with @CircAHA. #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos

crfheart's tweet image. 🧪✨ It’s the final late-breaker session at #TCT2025 — and it’s one you won’t want to miss! Experience the unveiling of groundbreaking research presented in collaboration with @CircAHA.

#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos…

David J. Cohen, MD, MSc hat repostet

🏆 Congratulations to Gennaro Giustino, MD (@g_giustinoMD) for receiving the Thomas J. Linnemeier Spirit of #InterventionalCardiology Young Investigator Award at #TCT2025! 🌟Your work is shaping the future of cardiovascular care. 👏 A huge shoutout to all the incredible…

crfheart's tweet image. 🏆 Congratulations to Gennaro Giustino, MD (@g_giustinoMD) for receiving the Thomas J. Linnemeier Spirit of #InterventionalCardiology Young Investigator Award at #TCT2025! 🌟Your work is shaping the future of cardiovascular care.

👏 A huge shoutout to all the incredible…
crfheart's tweet image. 🏆 Congratulations to Gennaro Giustino, MD (@g_giustinoMD) for receiving the Thomas J. Linnemeier Spirit of #InterventionalCardiology Young Investigator Award at #TCT2025! 🌟Your work is shaping the future of cardiovascular care.

👏 A huge shoutout to all the incredible…
crfheart's tweet image. 🏆 Congratulations to Gennaro Giustino, MD (@g_giustinoMD) for receiving the Thomas J. Linnemeier Spirit of #InterventionalCardiology Young Investigator Award at #TCT2025! 🌟Your work is shaping the future of cardiovascular care.

👏 A huge shoutout to all the incredible…

Loading...

Something went wrong.


Something went wrong.